A prediction rule based on a heel stiffness index and four clinical factors can identify which elderly women are at high risk of osteoporotic fracture.
A prediction rule based on a heel stiffness index and four clinical factors can identify which elderly women are at high risk of osteoporotic fracture, according to a report in the July issue of Radiology.
Idris Guessous, MD, from Lausanne University Hospital in Switzerland, and colleagues used heel-bone quantitative ultrasonographic data from 6,174 Swiss women (70 to 85 years old) to calculate the stiffness index at the heel and its predictive value for osteoporotic fractures.
The researchers assigned points to the five identified risk factors: older age, low heel quantitative ultrasonographic stiffness index, history of fracture, recent fall, and a failed chair test. A cutoff of 4.5 produced a sensitivity of 90% and identified 4,710 women at higher risk of fracture. More of these high-risk women had an osteoporotic fracture (6.1 vs. 1.8%), and 90% of women who had a hip fracture were in the high-risk group.
“A prediction rule obtained by using quantitative ultrasonographic stiffness index and four clinical risk factors helped discriminate, with high sensitivity, women at higher versus those at lower risk for osteoporotic fracture,” Guessous and colleagues conclude.
Guessous I, Cornuz J, Ruffieux C, et al. Osteoporotic fracture risk in elderly women: estimation with quantitative heel US and clinical risk factors.
Radiology
. 2008;248:179-184.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More